Christopher A. Todd

1.0k total citations
12 papers, 580 citations indexed

About

Christopher A. Todd is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Christopher A. Todd has authored 12 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Immunology. Recurrent topics in Christopher A. Todd's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and Influenza Virus Research Studies (3 papers). Christopher A. Todd is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and Influenza Virus Research Studies (3 papers). Christopher A. Todd collaborates with scholars based in United States. Christopher A. Todd's co-authors include David C. Montefiori, Marcella Sarzotti‐Kelsoe, Kelli Greene, Hongmei Gao, Daniel A. Ozaki, Miroslawa Bilska, Michael S. Seaman, Robert T. Bailer, John R. Mascola and Esra Abacı Türk and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Journal of Virology.

In The Last Decade

Christopher A. Todd

12 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Todd United States 9 369 212 193 140 120 12 580
Fatim Cham United States 12 361 1.0× 208 1.0× 205 1.1× 99 0.7× 97 0.8× 21 618
Kathryn E. Stephenson United States 15 364 1.0× 388 1.8× 207 1.1× 177 1.3× 178 1.5× 34 800
Lance Ching United States 9 424 1.1× 239 1.1× 339 1.8× 153 1.1× 140 1.2× 17 653
Stephanie Rainwater United States 11 769 2.1× 549 2.6× 260 1.3× 169 1.2× 87 0.7× 13 847
Nina D. Russell United States 14 349 0.9× 170 0.8× 280 1.5× 184 1.3× 212 1.8× 23 605
Peilin Li United States 15 505 1.4× 320 1.5× 290 1.5× 202 1.4× 120 1.0× 21 727
Katharine J. Bar United States 16 535 1.4× 470 2.2× 188 1.0× 188 1.3× 83 0.7× 53 750
F de Wolf Netherlands 10 759 2.1× 484 2.3× 286 1.5× 234 1.7× 106 0.9× 20 945
Lei Ba United States 13 444 1.2× 653 3.1× 160 0.8× 200 1.4× 102 0.8× 14 846
Donald S. Burke United States 8 397 1.1× 291 1.4× 95 0.5× 131 0.9× 59 0.5× 8 473

Countries citing papers authored by Christopher A. Todd

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Todd more than expected).

Fields of papers citing papers by Christopher A. Todd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Todd. The network helps show where Christopher A. Todd may publish in the future.

Co-authorship network of co-authors of Christopher A. Todd

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Todd. A scholar is included among the top collaborators of Christopher A. Todd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Todd. Christopher A. Todd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schmader, Kenneth E., Christine K. Liu, Brendan Flannery, et al.. (2023). Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial. Immunity & Ageing. 20(1). 30–30. 4 indexed citations
2.
Walter, Emmanuel B., Nicola P. Klein, A. Patricia Wodi, et al.. (2020). Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations. PEDIATRICS. 145(3). 6 indexed citations
3.
Keating, Sheila M., Wes Rountree, Eduard Grebe, et al.. (2019). Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay. PLoS ONE. 14(9). e0222290–e0222290. 8 indexed citations
4.
Edwards, James M., Nora L. Watson, Christopher A. Todd, et al.. (2019). Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study. Infectious Diseases in Obstetrics and Gynecology. 2019. 1–6. 59 indexed citations
5.
Walter, Emmanuel B., Christoph P. Hornik, Lisa A. Grohskopf, et al.. (2017). The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children. Vaccine. 35(48). 6664–6671. 9 indexed citations
6.
Edwards, James M., Nora L. Watson, Christopher A. Todd, et al.. (2017). Group B streptococcus (GBS) colonization and disease among pregnant women: a historical cohort study. American Journal of Obstetrics and Gynecology. 217(6). 731–731. 9 indexed citations
7.
Sarzotti‐Kelsoe, Marcella, Xiaoju Daniell, Christopher A. Todd, et al.. (2014). Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells. Journal of Immunological Methods. 409. 147–160. 32 indexed citations
8.
Todd, Christopher A., et al.. (2013). Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). Journal of Immunological Methods. 409. 91–98. 23 indexed citations
9.
Sarzotti‐Kelsoe, Marcella, Robert T. Bailer, Esra Abacı Türk, et al.. (2013). Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. Journal of Immunological Methods. 409. 131–146. 290 indexed citations
10.
Ozaki, Daniel A., Hongmei Gao, Christopher A. Todd, et al.. (2012). International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials. PLoS ONE. 7(1). e30963–e30963. 31 indexed citations
11.
Todd, Christopher A., Kelli Greene, Xuesong Yu, et al.. (2011). Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells. Journal of Immunological Methods. 375(1-2). 57–67. 50 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatim Cham Breakdown of academic impact, for papers by Kathryn E. Stephenson Breakdown of academic impact, for papers by Lance Ching Breakdown of academic impact, for papers by Stephanie Rainwater Breakdown of academic impact, for papers by Nina D. Russell Breakdown of academic impact, for papers by Peilin Li Breakdown of academic impact, for papers by Katharine J. Bar Breakdown of academic impact, for papers by F de Wolf Breakdown of academic impact, for papers by Lei Ba Breakdown of academic impact, for papers by Donald S. Burke
Rankless by CCL
2026